🇺🇸 Clarithromycin 500 mg in United States

36 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Nausea — 6 reports (16.67%)
  2. Drug Interaction — 5 reports (13.89%)
  3. Dysgeusia — 5 reports (13.89%)
  4. Insomnia — 5 reports (13.89%)
  5. Abdominal Pain Upper — 3 reports (8.33%)
  6. Oropharyngeal Pain — 3 reports (8.33%)
  7. Tinnitus — 3 reports (8.33%)
  8. Abdominal Pain — 2 reports (5.56%)
  9. Arthralgia — 2 reports (5.56%)
  10. Burning Sensation — 2 reports (5.56%)

Source database →

Clarithromycin 500 mg in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Clarithromycin 500 mg approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Clarithromycin 500 mg in United States?

Rehman Medical Institute - RMI is the originator. The local marketing authorisation holder may differ — check the official source linked above.